ATHA: Athira Pharma Inc Bozor narxining sof foydaga nisbati
Athira Pharma, Inc. (ATHA) uchun narxlar vizualizatsiyasi, qaysiki asosiy aktivlarni baholashga yordam beradi, -0.70 ko'rsatkichini namoyish etadi. Athira Pharma, Inc. (ATHA) neyropreparatlar yaratishda barqaror rivojlanish va etika tamoyillarini joriy etib, ishlab chiqarish tozaligini nazorat qiladi. Biznes, test natijalariga tayangan holda, demensiya uchun hujayralarni regeneratsiya qilish usullarini topishga e'tibor qaratadi. Laboratoriyalardagi avtomatlashtirilgan dozalash tizimlari va raqamli ma'lumotlar nazorati texnologik stekni to'ldiradi.
Athira Pharma Corp (ATHA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Barcha qarzlarning o‘z mablag‘lariga nisbati Athira Pharma, Inc.|ATHA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Athira Pharma|ATHA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Athira|ATHA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Athira Pharma|Oraliq qoplash koeffitsiyenti athira.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
ATHA - Sof foyda|Prognoz qilingan kelajakdagi foyda Athira Pharma, Inc.|ATHA - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Athira Pharma Corp|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Athira Pharma Inc|ATHA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Athira Pharma|ATHA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi athira.com|ATHA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Athira Pharma, Inc.
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning umumiy tahlili:Athira Pharma Inc - ATHA
P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini aks ettirib, investor emitentning joriy daromadlari uchun qanchalik ortiqcha to'lov qilayotganini belgilaydi. GURU.Markets platformasida IFRS P/E multiplikatorini tahlil qilishda, -0.70 qiymati regenerativ miya dori vositalarini ishlab chiqish bilan bog'liq xatarlarga nisbatan baholanishi kerak, chunki neyrobiologiya innovatori Athira Pharma, Inc. (ATHA) uchun ushbu ko'rsatkich ko'pincha joriy daromadlilikdan ko'ra kelajakdagi yutuqlar kutganlarini aks ettiradi.
Raqobatdosh kompaniyalar tahlili
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
